U$30 million of prepayment for licencing IY-81149 out to 6 foreign companies.

Published: 1999-12-23 13:38:00

Updated: 1999-12-23 13:38:00

Il Yang announced in the press interview on Dec. 21 at Palace hotel that the licence agreement was signed for an antipeptic ulcer drug, "IY-81149" with 6 foreign companies that were associated in consortium with Canadian Axcan pharmaceutical company, distributing it all over the world except Kore...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK